arrow
K

Kenneth Mangion

Cardiology
H指数:32
被引数:4,629

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Traditional left ventricular indices outperform novel cardiovascular magnetic resonance-derived left atrial parameters in predicting adverse left ventricular remodelling after ST-segment elevation myocardial infarction1

传统左心室指数优于新型心血管磁共振衍生的左心房参数,用于预测ST段抬高型心肌梗死后不良左心室重构

2026-05-250
OAAI
Pre-perfusion coronary wedge pressure and microvascular obstruction in anterior ST elevation myocardial infarction (STEMI): An analysis from the EUROICE study

术前灌注冠状动脉楔压和前壁ST段抬高型心肌梗死(STEMI)中的微血管阻塞:来自EUROICE研究的分析

2026-05-220
PRE
Infarct-Related Myocardial Resistance Before Reperfusion in Patients With Acute Myocardial Infarction to Predict Microvascular Injury and Clinical Outcomes

急性心肌梗死患者再灌注前梗死相关心肌阻力对微血管损伤和临床结局的预测作用

2025-11-011
PRE
Prospective Evaluation of the Cardiovascular Effects of BRAF and MEK Inhibitors in Patients With Melanoma

黑色素瘤患者中BRAF和MEK抑制剂心血管效应的前瞻性评估

2025-10-100
OAAI
Artificial intelligence fully automated analysis of handheld echocardiography in real-world patients with suspected heart failure

人工智能对疑似心力衰竭患者的手持式超声心动图进行全自动分析

2025-07-240
OAAI
Vascular endothelial growth factor inhibitor-induced cardiotoxicity: prospective multimodality assessment incorporating cardiovascular magnetic resonance imaging

血管内皮生长因子抑制剂诱导的心脏毒性:前瞻性多模态评估,包括心血管磁共振成像

HEART
IF4.4
2025-04-031
PRE
Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI)

Empliflozin预防心肌梗死后左心室容积和收缩功能恶化 (EMPRESS MI)

2024-12-150
PRE
Clinical Significance of Myocardial Injury in Patients Hospitalized for COVID-19 A Prospective, Multicenter, Cohort Study
2024-11-011
OAAI
2-Dimensional Echocardiographic Global Longitudinal Strain With Artificial Intelligence Using Open Data From a UK-Wide Collaborative

使用来自英国范围内的合作开放数据的人工智能二维超声心动图全球纵向应变

2024-08-011
OAAI
A randomised trial of selective intracoronary hypothermia during primary PCI
2024-06-012
PRE
Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design

Empagliflozin预防心肌梗死后进行性不良重塑 (empress-mi): 原理和设计

2024-05-075
OA